Company intelligence / Profile preview

Mercia Asset Management

Henley-in-Arden, West Midlands, UKmercia.co.uk ↗

Ownership: Private
Employees: ~140
Development stage: Other

Overview

As an asset manager/investor with a strong focus on UK regional businesses—including life sciences—Mercia has backed over 1,000 businesses with c.600 active in its current portfolio. Its life sciences investments represent a significant portion of value and include innovative biotechs such as NuVision Biotherapies and Aelius Biotech.

Recent notable exits include OXGENE and The Native Antigen Company.

It provides venture capital from seed/EIS/pre-Series A through growth/private equity stages.

It does not conduct clinical trials or develop drugs directly.

Therapeutic areas: GastroenterologyDermatologyOphthalmology
Modalities: BiologicDeviceSmall molecule
Industry: Investors

Partnerships

UK universitiesMidlands Engine Investment FundNorth East Venture FundNewable VenturesEuropean Regional Development Fund

Beyond the preview

Go deeper on Mercia Asset Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mercia Asset Management.

Explore the full profile